Isolated Limb Perfusions With Tumor Necrosis Factor and Melphalan for Locally Recurrent Soft Tissue Sarcoma in Previously Irradiated Limbs

[1]  A. Eggermont,et al.  Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable Stewart-Treves lymphangiosarcoma , 2002, Annals of Surgical Oncology.

[2]  A. Eggermont,et al.  Current uses of isolated limb perfusion in the clinic and a model system for new strategies. , 2003, The Lancet. Oncology.

[3]  M. Brennan,et al.  Extremity Soft Tissue Sarcomas , 2003 .

[4]  A. Eggermont,et al.  Fifty Tumor Necrosis Factor–Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors , 2003, Annals of surgical oncology.

[5]  M. Ballo,et al.  Brachytherapy for Locally Recurrent Soft-Tissue Sarcoma , 2002, American journal of clinical oncology.

[6]  W Hiddemann,et al.  Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. , 2001, European journal of cancer.

[7]  A. Stojadinovic,et al.  Amputation for Recurrent Soft Tissue Sarcoma of the Extremity: Indications and Outcome , 2001, Annals of Surgical Oncology.

[8]  A. Hart,et al.  Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  A. Eggermont,et al.  Systemic Toxicity and Cytokine/Acute Phase Protein Levels in Patients After Isolated Limb Perfusion With Tumor Necrosis Factor-a Complicated by High Leakage , 2000, Annals of Surgical Oncology.

[10]  A. Eggermont,et al.  Absence of Severe Systemic Toxicity After Leakage-Controlled Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan , 1999, Annals of Surgical Oncology.

[11]  K. Hunt,et al.  Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. , 1999, The cancer journal from Scientific American.

[12]  A. Davis,et al.  Soft tissue sarcoma of the extremity. Limb salvage after failure of combined conservative therapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  P. Schlag,et al.  Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. , 1996, Annals of surgery.

[14]  A. Eggermont,et al.  Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Eggermont,et al.  Isolated limb perfusion of an irradiated foot with tumor necrosis factor, interferon, and melphalan. , 1996, Archives of surgery.

[16]  H. Hoekstra,et al.  Soft tissue sarcoma of the extremity. , 1994, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  N. Renard,et al.  High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K. Schupak,et al.  Role of brachytherapy in recurrent extremity sarcoma in patients treated with prior surgery and irradiation. , 1991, International journal of radiation oncology, biology, physics.

[19]  M. Selch,et al.  Reirradiation for extremity soft tissue sarcomas. Local control and complications , 1991, Cancer.

[20]  A. Rydholm,et al.  Is local recurrence of minor importance for metastases in soft tissue sarcoma? , 1991, Cancer.

[21]  M. Selch,et al.  Reirradiation for Extremity Soft Tissue Sarcomas , 1991 .

[22]  C. Fisher,et al.  The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival , 1990, Cancer.

[23]  S. Rosenberg,et al.  High‐grade soft tissue sarcomas of the extremities , 1986, Cancer.

[24]  E. V. van Slooten,et al.  Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. , 1982, European journal of cancer & clinical oncology.